We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stem Cell-Based Cultures Used for Brain Disease Research

By LabMedica International staff writers
Posted on 08 Aug 2018
A team of neurological disease researchers used stem cell technology to culture mini-organoids comprising all the major cell types found in the human cerebral cortex - including oligodendrocytes - for brain structure/function research.

Oligodendrocytes make myelin, the fatty substance that wraps, supports, and insulates nerve cells and connections. More...
Nerve cells that lack myelin cannot communicate effectively and may degenerate.

Cerebral organoids have been shown to be an accessible system for investigations of cellular composition, interactions, and organization of the brain but have lacked oligodendrocytes. To correct this problem, investigators at Case Western Reserve University School of Medicine (Cleveland, OH, USA) reproducibly generated oligodendrocytes and myelin in "oligocortical spheroids" derived from human pluripotent stem cells.

The investigators reported in the July 25, 2018, online edition of the journal Nature Methods that molecular features consistent with those of maturing oligodendrocytes and early myelin appeared by week 20 in culture, with further maturation and myelin compaction evident by week 30.

Drugs that promoted myelin formation were found to enhance the rate and extent of oligodendrocyte generation and myelination, while spheroids generated from human subjects with the genetic myelin disorder Pelizaeus-Merzbacher disease recapitulated human disease phenotypes.

“We have taken the organoid system and added the third major cell type in the central nervous system—oligodendrocytes—and now have a more accurate representation of cellular interactions that occur during human brain development,” said senior author Dr. Paul Tesar, associate professor of genetics and genome sciences at Case Western Reserve University School of Medicine. “This is a powerful platform to understand human development and neurological disease. Using stem cell technology we can generate nearly unlimited quantities of human brain-like tissue in the lab. Our method creates a "mini-cortex", containing neurons, astrocytes, and now oligodendrocytes producing myelin. This is a major step toward unlocking stages of human brain development that previously were inaccessible.”

“Our method enables generation of human brain tissue in the laboratory from any patient,” said Dr. Tesar. “More broadly, it can accurately recapitulate how the human nervous system is built and identify what goes wrong in certain neurological conditions.”

Related Links:
Case Western Reserve University School of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Urine Analyzer
respons® UDS100
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.